Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
AMRN:NASDAQ
Amarin Corporation PLC
$14.56
-1.49%
(-0.22) 1D
May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMRN...
Open
$14.67
High
$15.24
Low
$14.24
Mkt. cap
301.53M
Avg. vol.
70.83K
Volume
55.90K
52-wk high
$20.90
52-wk low
$10.34
EPS
-$14.58
Beta
0.81
Shares outstanding
20.97M
No. of employees
80
News stories
From sources across the web
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
72.74M
49.67M
49.22M
45.13M
Cost of goods sold
22.38M
27.46M
26.05M
27.36M
Cost of revenue
22.38M
27.46M
26.05M
27.36M
Research and development expenses
4.92M
4.21M
5.37M
4.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.67M
19.70M
20.06M
21.12M
Operating expense
43.59M
23.90M
25.43M
25.78M
Total operating expenses
65.97M
51.37M
51.48M
53.14M
Operating income
6.77M
-1.70M
-2.26M
-8.01M
Other non operating income
-85.00K
205.00K
3.60M
188.00K
EBT including unusual items
-13.45M
-8.12M
-852.00K
-8.72M
EBT excluding unusual items
9.31M
1.29M
3.21M
-5.40M
Income tax expense
689.00K
-377.00K
372.00K
1.79M
Effective tax rate
-5.12%
4.65%
-43.66%
-20.51%
Other operating expenses
-
-
-
-
Net income
-14.14M
-7.74M
-1.22M
-10.51M
Net profit margin
-19.44%
-15.58%
-2.49%
-23.29%
Earnings per share
0.87
0.19
0.01
-
Interest and investment income
2.62M
2.78M
2.58M
2.42M
Interest expense
-
-
-7.00K
-
Net interest expenses
2.62M
2.78M
2.57M
2.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.50M
-830.00K
-1.56M
-7.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer